Corporate Universe Inc. (Pink Sheets:COUV) is a full fledged corporate consulting firm, with their (5) divisions: Manhattan Transfer Registrar Company; Advanta Management Consulting; Q Filers LLC; Corpprint LLC; and PR Universe LLC; The company covers all phases of the public sector and even many of the private sector, from stock transfers, to Edgar filing, to Public Relations to corporate printing to management consulting, they are a one stop corporate facilitator.
By providing multiple services Corporate Universe can provide �one stop� service at competitive prices.
Corporate Universe strategies include aggressively pursuing acquisitions, cross selling within subsidiaries, competitive pricing and advertising.
The Corporate Universe team offers guidance in mergers and acquisitions, reverse takeovers and extensive expertise in the regulatory processes to access capital markets. The Company also works closely with selected strategic partners to develop and execute funding strategies to accelerate growth. Mutual relationships of trust have always been the key to COUV and its network of partners.
Corporate Universe recently opened its new corporate office at 3771 Nesconset Highway, South Setauket, NY. The new office will allow Corporate Universe to operate all of its divisions and subsidiaries in a centrally located place. Manhattan Transfer Registrar Company will continue to be located in Miller Place.
Now that the corporate changes are fully implemented, including the name change to Corporate Universe Inc., trading under the symbol (Pink Sheets:COUV), and the forward split of 10 new shares for each old share of common stock, Corporate Universe is ready for business and intends to keep its followers advised on a timely basis.
MusclePharm Corporation (OTCBB:MSLP) announced a fulfillment agreement with IVitals that is expected to improve cash flow, reduce backorders, improve turnaround time on all orders and allow management to focus its time and resources on the marketing and selling of MusclePharm’s growing portfolio of products.
The Company expects to achieve over $4 million in sales for the full year of 2010, which is over 300% growth compared to the same period last year. The rapid growth and strong customer demand for the MusclePharm products has created back orders for 5 of the 12 months in 2010. The new fulfillment agreement is expect to greatly improve the back orders for the remainder of 2010 and reduce the insufficient levels of stock needed to complete all orders.
MusclePharm’s President, Cory Gregory stated, “This fulfillment agreement will reduce the cost and delivery time for all product shipments to our many retail and online customers. In addition, by outsourcing our fulfillment function, management will be able to focus our time and resources on expanding sales opportunities and enhancing our brand.”
Mr. Gregory continued, “With rapid growth of 300% come a few growing pains such as back orders. I am pleased that we expect to achieve this growth in 2010 despite having 40% of our orders on back-order. However, with this fulfillment agreement, we have greatly improved our operating platform and believe we have rectified our back order situation. With a dramatically improved operating platform and leading nutritional supplements that are 100% free of any banned substances we are very well positioned for continued strong growth in 2011.”
MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances.
The Law office of Brodsky & Smith, LLC announced on November 23, 2010 that it investigated potential claims against the Board of Directors J.Crew Group, Inc. (NYSE:JCG) relating to the proposed acquisition by funds affiliated with TPG Capital and Leonard Green & Partners, L.P. Under the terms of the transaction, JCrew shareholders would receive cash of $43.50 for each share of JCrew stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law. The transaction appears to be unfair, in part, given that JCrew traded at $50.00 a share as recently as April 26, 2010 and an analyst set a price target for JCrew at $50.00 per share. Thus, JCrew shareholders need additional information to know if the transaction is fair.
J.Crew Group, Inc. operates as an integrated multi-brand, multi-channel, and specialty retailer in the United States. The company designs, contracts for the manufacture of, markets, and distributes women�s, men�s, and children�s apparel; shoes; and accessories under the J.Crew, crewcuts, and Madewell brand names. Its J.Crew brand offers an assortment of women�s and men�s apparel and accessories, including wedding, swimwear, loungewear, outerwear, shoes, bags, belts, hair accessories, and jewelry.
Endurance Specialty Holdings Ltd. (NYSE:ENH) a Bermuda-based provider of property and casualty insurance and reinsurance, announced that its Board of Directors declared a quarterly dividend of $0.25 per ordinary share and $0.484375 per share payable on its 7.75% Non-Cumulative Preferred Shares, Series A. The dividend on Endurance�s outstanding ordinary shares will be payable on December 31, 2010 to the ordinary shareholders of record on December 17, 2010 and the dividend on Endurance�s Series A Preferred Shares will be payable on December 15, 2010 to the Series A Preferred shareholders of record on December 1, 2010.
Endurance Specialty Holdings Ltd., through its subsidiaries, engages in underwriting specialty lines of personal and commercial property and casualty insurance and reinsurance worldwide. Its Insurance segment offers property insurance of a commercial nature; casualty insurance for a range of industry groups; and healthcare liability line focusing on excess hospital medical professional liability insurance; and workers� compensation insurance.
McCormick & Co. Inc. (NYSE:MKC) declared on November 23, 2010 that an increase in the quarterly dividend from $0.26 to $0.28 per share on its common stocks, payable January 14, 2011 to shareholders of record December 31, 2010. This marks the 25th consecutive year that the Company has increased its quarterly dividend. Said Alan D. Wilson, Chairman, President & CEO, �Our dividend is an important way to share our success with McCormick�s shareholders. We are delivering high performance and have increased the dividend at an 11% compound annual growth rate since 2000.�McCormick has paid dividends every year since 1925.
McCormick & Company, Incorporated engages in the manufacture, marketing, and distribution of flavor products and other specialty food products to the food industry worldwide. It operates in two segments, Consumer and Industrial. The Consumer segment offers spices, herbs, extracts, seasoning blends, sauces, marinades, and specialty foods to the consumer food market through retail outlets, including grocery, mass merchandise, warehouse clubs, and discount and drug stores.
No comments:
Post a Comment